生物藥學研究所

Keyphrases

1. Polystyrene 100%
2. Hepatocellular Carcinoma 82%
3. Nanoparticles 74%
4. Atrial Fibrillation 74%
5. Taiwan 71%
6. Unsaturated Polyester Resin 71%
7. Resin 68%
8. Induced Apoptosis 65%
9. Carbon Nanofibers 63%
10. SHP-1 60%
11. Apoptosis 49%
12. Mold Filling 46%
13. Small Interfering RNA (siRNA) 45%
14. Low Temperature 45%
15. Sorafenib 44%
16. Nanoclay 43%
17. Nanopaper 43%
18. Overexpression 42%
19. Liquid Composite Molding 41%
20. Chemotherapy 41%
21. Mechanical Properties 40%
22. Poly(methyl methacrylate) 40%
23. Carbon Dioxide 40%
24. Catheter Ablation 39%
25. Sheet Molding Compound 39%
26. Hepatocellular Carcinoma Cells 36%
27. Confidence Interval 36%
28. Overall Survival 35%
29. Injection Molding 35%
30. Resin Transfer Molding 35%
31. Polyurethane 35%
32. 5-fluorouracil (5-FU) 33%
33. Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 33%
34. Non-Hodgkin Lymphoma 32%
35. Zebrafish 32%
36. Lung Cancer 32%
37. Acute Myeloid Leukemia 31%
38. Tumor 31%
39. CIP2A 31%
40. Metastatic Colorectal Cancer (mCRC) 30%
41. Reaction Kinetics 30%
42. Colorectal Cancer 30%
43. Prognostic Factors 30%
44. Styrene 30%
45. Gene Expression 30%
46. Fiber Mats 29%
47. Extracellular Vesicles 29%
48. Viscosity 29%
49. Liver 28%
50. Non-small Cell Lung Cancer (NSCLC) 28%
51. Electroporation 28%
52. Risk Factors 28%
53. Supercritical Carbon Dioxide 28%
54. Unsaturated Polyester 28%
55. Caenorhabditis Elegans 28%
56. B-cell Lymphoma 2 (Bcl-2) 27%
57. Head-and-neck Squamous Cell Carcinoma (HNSCC) 27%
58. Glass Transition Temperature 27%
59. Reaction Injection Molding 27%
60. Aurora A 26%
61. Extrusion Foaming 26%
62. Blowing Agent 26%
63. Ablation 26%
64. Compression Molding 26%
65. Microfluidics 26%
66. Rheological Change 25%
67. Phosphorylation 25%
68. Ventricular Arrhythmia 25%
69. Knockdown 25%
70. Autophagy 25%
71. Nanochannel 24%
72. Heat Transfer 24%
73. Molding Process 24%
74. Hematopoietic Stem Cell Transplantation 24%
75. Thymosin 23%
76. Diffuse Large B-cell Lymphoma (DLBCL) 23%
77. Lipid Nanoparticles 23%
78. Polyester 23%
79. MicroRNA 23%
80. Fiber Preform 23%
81. Free Radicals 23%
82. Multivariate Analysis 23%
83. Cisplatin 22%
84. Reaction Rate 22%
85. Lipoplexes 22%
86. Rituximab 22%
87. Graft-versus-host Disease (GvHD) 21%
88. Shrinkage Control 21%
89. In Cancer 21%
90. Polystyrene Foam 21%
91. Pulmonary Vein Isolation 21%
92. Signal Transducer and Activator of Transcription 3 21%
93. Protein Phosphatase 2A (PP2A) 21%
94. Activated Carbon 21%
95. Structural Reaction Injection Moulding 21%
96. Cytotoxicity 20%
97. Polymer Nanocomposites 20%
98. Hazard Ratio 20%
99. Low-profile Additives 20%
100. Protein-protein Interaction 20%